Community Clinical Oncology Program
Research Base Protocol Credit Assignment
Approved, Active, and Closed Protocols

Research Base Cancer and Leukemia Group B (CALGB)
qry_Credit_Report_Output_HTML_CALGB
Protocol Number Type of Cancer or Study Intergroup Number Coordinating Center Study Status Closure Date Treatment Credit Cancer Control Credit Followup Credit Followup Years Credit Description
C19807 Leukemia, Chronic C19807 CALGB CL 5/15/2001 1
0 0
C59910 Lymphomas Non-Hodgkin's
CALGB CL 2/15/2002 1
0 0
C80405 Gastrointestinal C80405 CALGB AC
1 0.3 0 0 0.3 Cancer Control Credit for QOL. Sample size for QOL component is 462 out of the overall study sample of N=2289. QOL component approved 9/19/2007
C89803 Gastrointestinal C89803 CALGB CL 5/15/2001 1 0 0 0
C9581 Gastrointestinal C9581 CALGB CL 5/31/2002 1.1 0 0 0 0.1 CREDIT FOR MARKER STUDY
C9732 Lung C9732 CALGB CL 7/13/2001 1 0 0 0
C9734 Lung Non-Small Cell C9734 CALGB CL 6/30/2000 1 0 0 0
C9781 Other
CALGB CL 3/30/2000 1 0 0 0
C9864 Gastrointestinal
CALGB CL 4/30/2002 1
0 0
CALGB 170601


DCP Approved
0 1 0

CALGB 360401


Active
0 0.5 0 0
CALGB 70305


Active
0 1 0

CALGB 70501


Active
0 1 0

CALGB 79805 Intervention Study

Closed 12/30/2005
1

Cancer Control credit increased from 0.5 to 1.0 as of June 1, 2003
CALGB 79806 Intervention Study

Closed 6/5/2006
1


CALGB-100001 Other
CALGB AC
1
0 0
CALGB-100002 Leukemia, Chronic
CALGB CL 3/31/2006 1
0 0
CALGB-10001 Leukemia, Acute
CALGB AC
1
0 0
CALGB-10002 Lymphomas
CALGB AC
1
0 0
CALGB-10003 Leukemia, Chronic
CALGB CL 5/23/2005 1
0 0
CALGB-100103 Leukemia, Acute
CALGB AC
1 0 0 0
CALGB-100104 Other CALGB-100104 CALGB AC
1 0 0 0
CALGB-10101 Leukemia, Chronic
CALGB CL 12/15/2006 1
0 0
CALGB-10102 Leukemia, Acute CALGB-10102 CALGB CL 5/2/2007 1 0 0 0
CALGB-10103 Leukemia, Chronic E2997 ECOG CL 3/19/2004 1 0 0 0
CALGB-10105 Other
CALGB AC
1 0 0 0
CALGB-10107 Leukemia, Chronic
CALGB CL 3/29/2005 1 0 0 0
CALGB-10201 Leukemia, Acute CALGB-10210 CALGB CL 10/20/2006 1 0 0 0
CALGB-10301 Other
CALGB CL 10/25/2005 1
0 0
CALGB-10303 Leukemia, Chronic S0325 SWOG AC
1 0 0 0
CALGB-10403 Leukemia, Acute CALGB-10403 CALGB AC
1 0 0 0
CALGB-10404 Leukemia, Chronic CALGB-10404 CALGB AC
1 0 0 0
CALGB-10501 Leukemia, Chronic CALGB-10501 CALGB AC
1 0.3 0 0 0.3 Cancer Control credit for QOL
CALGB-10503 Gastric
CALGB AC
1 0 0 0
CALGB-10602 Leukemia, Acute E1905 ECOG AC
1 0 0 0
CALGB-109901 Leukemia, Chronic
CALGB CL 4/28/2006 1
0 0
CALGB-140202 Lung
CALGB AC
0 0 0 0 No credit assigned for Tissue Banking protocols
CALGB-140203 Lung Non-Small Cell
CALGB CL 1/31/2007 1 0 0 0
CALGB-140302 Gastrointestinal E2202 ECOG AC
1 0 0 0
CALGB-140503 Lung Non-Small Cell CALGB-140503 CALGB AC
1 0 0 0
CALGB-150005 Genitourinary
CALGB CL 10/1/2004 0
0 0 Study uses serum samples stored from prior trial therefore no credit assigned.
CALGB-150008 Gastrointestinal
CALGB AC
0.1
0 0
CALGB-159803 Lung

CL 6/20/2003 0 0 0 0 NO CREDIT
CALGB-159805 Breast

CL 7/15/2004 0
0 0 NO CREDIT
CALGB-159806 Breast
CALGB CL 8/13/2004 0.1
0 0 Companion to CALGB-9342
CALGB-159902 Lung Non-Small Cell
CALGB CL 9/30/2003 0.1
0 0
CALGB-159905 Breast

AC
0
0 0 NO CREDIT
CALGB-19801 Leukemia, Acute CALGB-19801 CALGB CL 9/12/2001 1 0 0 0
CALGB-19802 Leukemia, Acute
CALGB CL 1/5/2001 1 0 0 0
CALGB-19803 Other
CALGB CL 5/31/2000 1 0 0 0
CALGB-19804 Leukemia, Chronic
CALGB CL 3/11/2002 1 0 0 0
CALGB-19805 Leukemia, Chronic
CALGB CL 7/3/2002 1 0 0 0
CALGB-19808 Leukemia, Acute
CALGB CL 3/31/2006 1
0 0
CALGB-19901 Leukemia, Chronic
CALGB CL 2/28/2002 1
0 0
CALGB-19902 Leukemia, Acute
CALGB CL 5/6/2004 1 0 0 0
CALGB-19903 Leukemia, Acute E2998 ECOG CL 10/1/2001 1
0 0
CALGB-29801 Leukemia, Chronic
CALGB AC
0.1 0 0 0
CALGB-30002 Lung Non-Small Cell
CALGB CL 1/31/2003 1
0 0
CALGB-30004 Lung Non-Small Cell
CALGB CL 4/30/2003 1
0 0
CALGB-30101 Other
CALGB CL 3/14/2002 1
0 0
CALGB-30102 Lung CALGB-30102 CALGB CL 12/28/2004 1 0.3 0 0 0.3 cc credit for QOL
CALGB-30103 Lung Non-Small Cell
CALGB CL 10/29/2004 1
0 0
CALGB-30104 Lung
CALGB CL 8/15/2003 1 0 0 0
CALGB-30105 Lung Non-Small Cell
CALGB CL 11/30/2004 1
0 0
CALGB-30106 Other
CALGB CL 4/28/2005 1
0 0
CALGB-30107 Other
CALGB CL 11/30/2004 1
0 0
CALGB-30201 Lung N0124 NCCTG CL 7/2/2004 1 0 0 0
CALGB-30202 Lung RTOG-0241 RTOG CL 11/24/2005

0 0
CALGB-30203 Lung Non-Small Cell
CALGB CL 9/30/2004 1 0 0 0 No QOL objectives, hypothesis or endpoints or statistical plan i.e. no CC credit
CALGB-30206 Lung
CALGB CL 9/30/2005 1 0 0 0
CALGB-30303 Lung Non-Small Cell
CALGB CL 3/10/2006 1
0 0
CALGB-30304 Lung
CALGB CL 2/15/2006 1
0 0
CALGB-30305 Lung RTOG-0212 RTOG CL 3/3/2008 1 0.5 0 0 0.5 Cancer Control credit for QOL
CALGB-30306 Lung
CALGB CL 4/10/2006 1 0 0 0
CALGB-30307 Other
CALGB CL 8/15/2005 1 0 0 0
CALGB-30402 Lung Non-Small Cell
CALGB CL 9/28/2006 1 0 0 0
CALGB-30406 Lung
CALGB AC
1 0 0 0
CALGB-30407 Lung Non-Small Cell
CALGB CL 1/2/2008 1 0 0 0
CALGB-30501 Lung Non-Small Cell S0220 SWOG CL 10/1/2007 1 0 0 0
CALGB-30504 Lung
CALGB AC
1 0 0 0
CALGB-30601 Other
CALGB AC
1 0 0 0
CALGB-30602 Lung
CALGB AC
1 0 0 0
CALGB-30605 Lung Non-Small Cell
CALGB AC
1 0 0 0
CALGB-30610 Lung CALGB-30610 CALGB AC
1 0.5 0 0 0.5 Cancer Control Credit for QOL component
CALGB-39801 Lung Non-Small Cell CALGB-39801 CALGB CL 5/31/2002 1 0 0 0
CALGB-39803 Lung Non-Small Cell
CALGB CL 9/30/2003 1 0 0 0
CALGB-39804 Lung
CALGB CL 9/29/2000 1 0.5 0 0 0.5 CC CREDIT IS FOR QOL COMPONENT
CALGB-39805 Lung Non-Small Cell
CALGB CL 1/31/2000 1 0 0 0
CALGB-39807 Brain
CALGB CL 8/31/2001 1
0 0
CALGB-39808 Lung Non-Small Cell
CALGB CL 6/15/2000 1 0 0 0
CALGB-39809 Lung Non-Small Cell
CALGB CL 10/31/2000 1
0 0
CALGB-39810 Lung Non-Small Cell
CALGB CL 7/19/2002 1
0 0
CALGB-39901 Lung
CALGB CL 4/30/2002 1
0 0
CALGB-39902 Lung
CALGB CL 9/28/2001 1
0 0
CALGB-39904 Lung Non-Small Cell
CALGB CL 7/29/2005 1
0 0
CALGB-40101 Breast CALGB-40101 CALGB AC
1 0 0 0 Companion CALGB-70301 see separate credit assignment
CALGB-40105 Breast
CALGB CL 3/24/2005 1
0 0
CALGB-40302 Breast CALGB-40302 CALGB AC
1 0 0 0
CALGB-40504 Breast E2104 ECOG CL 11/6/2006 1 0 0 0
CALGB-49801 Breast RTOG 98-04 RTOG CL 7/14/2006 1
0 0
CALGB-49802 Breast E2197 ECOG CL 1/21/2000 1
0 0
CALGB-49805 Breast MA.17 NCIC CL 5/31/2002 1 0.5 0 0 0.5 CC CREDIT FOR QOL
CALGB-49806 Breast
CALGB CL 2/28/2002 1
0 0
CALGB-49808 Breast CALGB-49808 CALGB CL 12/15/2002 1
0 0
CALGB-49901 Breast S9630 SWOG CL 12/15/2004 0.8 0.5 0 0
CALGB-49906 Breast E1199 ECOG CL 1/8/2002 1
0 0
CALGB-49907 Breast CALGB-49907 CALGB CL 12/29/2006 1 0.2 0 0 Assignment changed to 0.2 CC credits for sites and research base. Original assignment = 0.5 cc credit for QOL to the CALGB Research Base only.
CALGB-49909 Breast N9831 NCCTG CL 4/30/2005 1
0 0
CALGB-49910 Breast S9927 SWOG CL 6/15/2003 1
0 0
CALGB-500001 Melanoma
CALGB CL 3/15/2004 1
0 0
CALGB-500002 Melanoma S0008 SWOG CL 1/31/2007 1 0 0 0
CALGB-50002 Lymphomas
CALGB CL 4/29/2004 1
0 0
CALGB-500101 Melanoma E4697 ECOG CL 10/31/2006 1 0 0 0
CALGB-500102 Melanoma
CALGB CL 3/15/2005 1 0 0 0
CALGB-500103 Melanoma E1697 ECOG CL 1/31/2007 1 0.5 0 0 0.5 CC Credit is for QOL
CALGB-500104 Melanoma
CALGB CL 8/1/2005 1 0 0 0
CALGB-500105 Melanoma
CALGB CL 3/10/2006 0.2 0 0 0
CALGB-50102 Lymphomas S0016 SWOG AC
1 0 0 0
CALGB-50103 Lymphomas Non-Hodgkin's
CALGB CL 5/28/2004 1
0 0
CALGB-50201 Lymphomas Non-Hodgkin's
CALGB CL 4/13/2007 1 0 0 0
CALGB-50202 Lymphomas
CALGB AC
1 0 0 0
CALGB-50203 Lymphomas, Hodgkin's Disease
CALGB CL 9/29/2006 1 0 0 0
CALGB-50205 Lymphomas E2499 ECOG CL 5/26/2006 1 0 0 0
CALGB-50206 Lymphomas, Hodgkin's Disease
CALGB CL 2/23/2005 1 0 0 0
CALGB-50303 Lymphomas CALGB-50303 CALGB AC
1 0 0 0
CALGB-50401 Lymphomas Non-Hodgkin's
CALGB AC
1 0 0 0
CALGB-50402 Lymphomas Non-Hodgkin's
CALGB CL 6/30/2006 1 0 0 0
CALGB-50403 Lymphomas
CALGB AC
1 0 0 0
CALGB-50404 Lymphomas Non-Hodgkin's
CALGB CL 12/29/2006 1 0 0 0
CALGB-50501 Lymphomas
CALGB AC
1 0 0 0
CALGB-50502 Lymphomas, Hodgkin's Disease
CALGB CL 12/4/2007 1 0 0 0
CALGB-50602 Lymphomas
CALGB AC
1 0 0 0
CALGB-50701 Lymphomas Non-Hodgkin's
CALGB AC
1 0 0 0
CALGB-509801 Melanoma E1694 ECOG CL 10/15/1999 1 0 0 0
CALGB-509802 Melanoma E3695 ECOG CL 4/17/2002 1
0 0
CALGB-509901 Melanoma
CALGB CL 7/15/2003 1
0 0
CALGB-59802 Lymphomas, Hodgkin's Disease S9901 SWOG CL 11/1/2001 1
0 0
CALGB-59804 Lymphomas, Hodgkin's Disease
CALGB CL 7/22/2003 1
0 0
CALGB-59901 Lymphomas
CALGB CL 3/15/2004 1
0 0
CALGB-59902 Lymphomas E1496 ECOG CL 5/2/2003 1
0 0
CALGB-59903 Lymphomas Non-Hodgkin's S9704 SWOG CL 12/15/2007 1
0 0
CALGB-59905 Lymphomas, Hodgkin's Disease E2496 ECOG CL 6/15/2006 1
0 0
CALGB-59906 Lymphomas Non-Hodgkin's
CALGB CL 8/4/2003 1 0 0 0
CALGB-59908 Lymphomas
CALGB CL 1/29/2003 1
0 0
CALGB-59909 Lymphomas
CALGB CL 10/29/2004 1
0 0
CALGB-60001 Other
CALGB CL 4/30/2003 0.1
0 0
CALGB-60101 Other
CALGB CL 5/6/2005 1
0 0
CALGB-69803 Other
CALGB CL 1/31/2002 1
0 0
CALGB-69901 Genitourinary
CALGB CL 8/19/2002 1
0 0
CALGB-70004 Intervention Study S9917
Closed 11/1/2006
1 0.3

CALGB-70301 Breast CALGB-70301 CALGB AC
0 0.2 0 0 Retroactive to June 1, 2005
CALGB-79802 Intervention Study EZ196
Closed 1/14/2000
1 0

CALGB-79803 Intervention Study E5597
Active

1 0.3

CALGB-79804 Descriptive

Closed 11/15/2001 0 0


CALGB-79809 Intervention Study

Closed 2/28/2006
1

Cancer Control credit increased from 0.8 to 1.0 as of June 1, 2003
CALGB-79901 Intervention Study DM96-256
Closed 8/23/2002
0.7


CALGB-80002 Gastrointestinal CALGB-80002 CALGB CL 8/29/2003 1
0 0
CALGB-80003 Other
CALGB CL 10/29/2004 1
0 0
CALGB-80004 Other S0033 SWOG CL 9/1/2001 1
0 0
CALGB-80101 Gastric CALGB-80101 CALGB AC
1 0 0 0
CALGB-80203 Gastrointestinal CALGB-80203 CALGB CL 1/15/2005 1 0 0 0 No Cancer Control credit for QOL
CALGB-80302 Gastrointestinal
CALGB AC
1 0 0 0
CALGB-80303 Gastrointestinal CALGB-80303 CALGB CL 4/14/2006 1 0 0 0
CALGB-80402 Gastrointestinal
CALGB CL 3/21/2007 1 0 0 0
CALGB-80403 Gastrointestinal CALGB-80403 CALGB AC
1 0 0 0
CALGB-80603 Gastrointestinal
CALGB CL 11/2/2007 1 0 0 0
CALGB-8361 Leukemia, Acute
CALGB CL 5/30/1997 0.1 0 0 0
CALGB-8362 Leukemia, Acute

CL 3/30/1992 0 0.3 0 0
CALGB-8364 Leukemia, Acute
CALGB CL 4/15/1999 0.1 0 0 0
CALGB-8461 Other
CALGB AC
0.1 0 0 0
CALGB-8534 Lung
CALGB CL 8/12/1992 1 0 0 0
CALGB-8636 Lung
CALGB CL 1/11/1989 1.2 0 0 0
CALGB-8761 Leukemia, Chronic
CALGB CL 1/31/1996 0.1 0 0 0
CALGB-8762 Leukemia, Acute
CALGB CL 4/15/1999 0.1 0 0 0
CALGB-8763 Leukemia, Acute
CALGB CL 5/31/1996 0.1 0 0 0
CALGB-8812 Other

CL 8/26/1992 1 0 0 0
CALGB-8837 Lung

CL 12/29/1994 1 0 0 0
CALGB-8841 Breast

CL 11/12/1992 1 0 0 0
CALGB-8861 Breast
CALGB CL 9/1/1999 0.1 0 0 0
CALGB-8862 Other

CL 9/20/1991 0.2 0 0 0
CALGB-8867 Lung

CL 9/1/1992 0 0 0 0 CREDIT COVERED IN COMPANION PROTOCOL
CALGB-8869 Other
CALGB CL 8/15/2001 0.1 0 0 0
CALGB-8872 Intervention Study

Closed 1/15/1993 0 0.7


CALGB-8891 Genitourinary INT-0080 SWOG CL 7/1/1998 1.5 0 0 0 HIGH PRIORITY APPROVAL
CALGB-8911 Other

CL 1/7/1992 1 0 0 0
CALGB-8912 Other

CL 10/11/1991 1 0 0 0
CALGB-8922 Leukemia, Acute

CL 8/24/1992 1 0 0 0
CALGB-8935 Lung Non-Small Cell

CL 2/24/1992 1 0 0 0
CALGB-8945 Breast

CL 8/28/1992 1 0 0 0
CALGB-8951 Lymphomas Non-Hodgkin's

CL 11/6/1991 1 0 0 0
CALGB-8952 Lymphomas, Hodgkin's Disease INT-0111 CALGB CL 11/10/1995 1 0 0 0
CALGB-8961 Other
CALGB CL 9/30/1996 0.1 0 0 0
CALGB-8962 Lymphomas, Hodgkin's Disease

CL 3/1/1992 0.1 0 0 0
CALGB-8963 Descriptive

Closed 7/30/1993 0 0.1


CALGB-8965 Other

CL 2/24/1992 0.1 0 0 0
CALGB-8966 Gastrointestinal

CL 3/31/1992 0 0 0 0 CREDIT COVERED IN COMPANION PROTOCOL
CALGB-8971 Intervention Study

Closed 5/15/1993 0 0.5


CALGB-89804 Gastrointestinal N9741 NCCTG CL 7/18/2002 1 0.3 0 0 0.3 CC Credit for QOL
CALGB-89805 Pancreatic
CALGB CL 12/10/1999 1 0 0 0
CALGB-89808 Gastrointestinal INT-0157 RTOG CL 6/27/2005 1
0 0
CALGB-8984 Gastrointestinal

CL 10/15/1995 1 0 0 0
CALGB-89901 Gastrointestinal
CALGB CL 11/21/2003 1
0 0
CALGB-89902 Gastrointestinal
CALGB CL 12/31/2002 1
0 0
CALGB-89903 Gastrointestinal
CALGB CL 10/13/2004 1
0 0
CALGB-89904 Other
CALGB CL 12/12/2003 1
0 0
CALGB-8991 Genitourinary EST-3887 ECOG CL 4/9/1992 1 0 0 0
CALGB-90003 Genitourinary CALGB-90003 CALGB CL 4/15/2004 1
0 0
CALGB-90004 Genitourinary
CALGB CL 1/7/2004 1 0 0 0
CALGB-90006 Genitourinary
CALGB CL 11/1/2002 1
0 0
CALGB-90008 Genitourinary
CALGB CL 5/1/2003 1
0 0
CALGB-90101 Genitourinary
CALGB CL 4/15/2004 1
0 0
CALGB-90102 Genitourinary
CALGB CL 4/8/2005 1
0 0
CALGB-90104 Genitourinary CALGB-90104 CALGB CL 7/15/2005 1 0 0 0
CALGB-90105 Other
CALGB CL 10/31/2003 1 0 0 0
CALGB-90106 Other CALGB-90106 CALGB CL 4/1/2005 1 0 0 0
CALGB-9011 Leukemia, Chronic

CL 12/7/1994 1 0 0 0
CALGB-90202 Genitourinary CALGB-90202 CALGB AC
1 0 0 0
CALGB-90203 Genitourinary CALGB-90203 CALGB AC
1 0 0 0
CALGB-90206 Genitourinary CALGB-90206 CALGB CL 7/1/2005 1 0 0 0
CALGB-90207 Genitourinary
CALGB CL 4/8/2005 1 0 0 0
CALGB-9021 Leukemia, Chronic

CL 11/30/1995 1 0 0 0
CALGB-9022 Leukemia, Acute

CL 3/31/1992 1 0 0 0
CALGB-90401 Genitourinary CALGB-90401 CALGB CL 12/21/2007 1 0 0 0
CALGB-9041 Breast

CL 3/2/1995 1 0 0 0
CALGB-9051 Lymphomas, Hodgkin's Disease

CL 6/26/1992 1 0 0 0
CALGB-9061 Lymphomas

CL 7/31/1992 0.1 0 0 0
CALGB-9066 Breast

CL 9/30/1994 0 0.5 0 0 COMPANION TO CALGB-9082
CALGB-9072 Pilot Study

Closed 11/1/1991 0 0.5


CALGB-9081 Gastrointestinal INT-0114
CL 11/22/1992 1.5 0 0 0 HIGH PRIORITY APPROVAL
CALGB-9082 Breast
CALGB CL 5/29/1998 1.5 0 0 0 HIGH PRIORITY APPROVAL ON 6/91
CALGB-9091 Gastrointestinal INT-0113 RTOG CL 12/31/1995 1 0 0 0
CALGB-9092 Gastrointestinal
ECOG CL 10/6/1995 1 0 0 0
CALGB-9111 Leukemia, Acute

CL 7/30/1993 1 0 0 0
CALGB-9113 Leukemia, Acute

CL 10/15/1996 1 0 0 0
CALGB-9120 Leukemia, Acute EST-3489 ECOG CL 2/15/1995 1.5 0 0 0 HIGH PRIORITY APPROVAL
CALGB-9130 Lung Non-Small Cell

CL 7/29/1994 1 0 0 0
CALGB-9131 Other

CL 9/15/1994 1 0 0 0
CALGB-9132 Lung Non-Small Cell

CL 3/18/1992 1 0 0 0
CALGB-9133 Lung Non-Small Cell

CL 7/31/1995 1 0 0 0
CALGB-9134 Lung Non-Small Cell

CL 12/15/1994 1 0 0 0
CALGB-9140 Breast

CL 8/15/1995 1 0 0 0
CALGB-9150 Lymphomas Non-Hodgkin's

CL 12/15/1995 1 0 0 0
CALGB-9155 Lymphomas

CL 9/30/1996 1 0 0 0
CALGB-9160 Other

CL 3/31/1995 1 0 0 0
CALGB-9170 Intervention Study

Closed 1/15/1999 0 1


CALGB-9181 Genitourinary

CL 6/24/1994 1 0 0 0
CALGB-9182 Genitourinary

CL 9/15/1995 1 0 0 0
CALGB-9190 Melanoma EST-1690 ECOG CL 6/1/1995 1.5 0 0 0 HIGH PRIORITY APPROVAL; 1.0 THRU 5/31/91; 1.5 STARTING 6/1/91
CALGB-9191 Leukemia, Acute INT-0129 ECOG CL 2/1/1995 1 0 0 0
CALGB-9194 Breast INT-0100 SWOG CL 8/1/1995 1 0 0 0
CALGB-9195 Gastrointestinal INT-0116 SWOG CL 7/15/1998 1.5 0 0 0 HIGH PRIORITY APPROVAL
CALGB-9211 Leukemia, Chronic

CL 12/18/1996 1 0 0 0
CALGB-9221 Other
CALGB CL 4/9/1996 1 0 0 0
CALGB-9222 Leukemia, Acute

CL 12/31/1995 1 0 0 0
CALGB-9234 Other

CL 9/30/1994 1 0 0 0
CALGB-9235 Lung

CL 1/15/1999 1 0 0 0
CALGB-9236 Lung

CL 7/15/1996 1 0 0 0
CALGB-9237 Lung
CALGB CL 8/31/1995 1 0 0 0
CALGB-9238 Lung
CALGB CL 7/15/1998 0 0 0 0
CALGB-9242 Breast

CL 6/15/1994 1 0 0 0
CALGB-9243 Breast

CL 6/8/1995 1 0 0 0
CALGB-9251 Lymphomas

CL 2/29/2000 1 0 0 0 COMPANION TO CALGB-8364
CALGB-9252 Lymphomas Non-Hodgkin's

CL 3/31/1995 0 0 0 0 NO CREDIT; COMPANION TO 9154, 8852, 8854
CALGB-9254 Other

CL 3/18/1997 1 0 0 0
CALGB-9255 Lymphomas, Hodgkin's Disease

CL 5/15/1997 1 0 0 0
CALGB-9256 Lymphomas

CL 11/6/1995 1 0 0 0
CALGB-9264 Other

CL 9/29/1995 1 0 0 0
CALGB-9267 Lung Non-Small Cell

CL 4/15/1996 0.1 0 0 0
CALGB-9270 Intervention Study CALGB-9270
Closed 1/3/2000 0 1 0.3
1 CREDIT FOR YR 1; 0.3 FOR ADD'L YRS.
CALGB-9281 Gastrointestinal

CL 7/24/1998 1 0 0 0
CALGB-9293 Lung I91-0001 MDA CL 3/19/1997 0 1 0 0 1.0 CREDIT FOR YEAR ONE; 0.3 CREDIT FOR EACH ADDITIONAL YEAR
CALGB-9294 Gastrointestinal INT-0130 NCCTG CL 12/17/1996 1.5 0 0 0 HIGH PRIORITY
CALGB-9311 Leukemia, Acute
CALGB CL 9/30/1994 1 0 0 0
CALGB-9312 Other INT-0141 SWOG CL 10/1/2000 1.5 0 0 0
CALGB-9331 Lung
CALGB CL 3/31/1997 1 0 0 0
CALGB-9332 Lung
CALGB CL 2/15/1996 1 0 0 0
CALGB-9334 Other
CALGB CL 9/30/1999 0 0 0 0 THIS WAS REVIEWED IN CTEP WITH DCPC INCLUDED. THIS STUDY IS FUNDED UNDER A U-05.
CALGB-9335 Lung
CALGB CL 9/30/1999 0 0 0 0 THIS STUDY IS FUNDED UNDER A U-05
CALGB-9336 Lung
CALGB CL 4/17/1996 0 0 0 0 FUNDED UNDER A U05
CALGB-9342 Breast
CALGB CL 7/31/1997 1 0 0 0
CALGB-9343 Breast
CALGB CL 2/26/1999 1 0 0 0
CALGB-9344 Breast INT-0148 CALGB CL 4/15/1997 1 0 0 0 ECOG (9344), NCCTG (94-30-51), AND SWOG (9410) ALSO PARTICIPATE
CALGB-9351 Lymphomas Non-Hodgkin's
CALGB CL 7/31/1996 1 0 0 0
CALGB-9364 Other
CALGB CL 9/15/1996 0 0 0 0
CALGB-9365 Gastrointestinal
CALGB CL 9/29/1998 0.1 0 0 0
CALGB-9371 Intervention Study

Closed 6/15/1998 0 0.5


CALGB-9380 Head and Neck
CALGB CL 9/24/1999 0 0 0 0 FUNDED UNDER A U05
CALGB-9390 Melanoma
ECOG CL 6/1/1995 1 0 0 0
CALGB-9391 Lymphomas, Hodgkin's Disease
SWOG CL 4/20/2000 1 0 0 0
CALGB-9393 Lung Non-Small Cell
ECOG CL 2/4/1997 1.5 0 0 0 HIGH PRIORITY
CALGB-9394 Breast INT-0137 SWOG CL 5/1/1997 1 0 0 0
CALGB-9395 Gastrointestinal INT-0136 ECOG CL 5/19/2000 1 0 0 0
CALGB-9396 Gastrointestinal INT-0146 NCCTG CL 8/30/2001 0 0 0 0 NO CREDIT--FUNDED UNDER A DIFFERENT MECHANISM
CALGB-9399 Genitourinary
SWOG CL 12/31/1996 0 1 0 0 1 CREDIT FOR YEAR ONE; 0.3 CREDIT FOR EACH ADDITIONAL YEAR.
CALGB-9411 Other
CALGB CL 11/15/1997 0 0 0 0
CALGB-9420 Leukemia, Acute
CALGB CL 7/29/1997 1 0 0 0
CALGB-9430 Lung
CALGB CL 6/15/1999 1 0 0 0
CALGB-9431 Lung Non-Small Cell
CALGB CL 6/30/1998 1 0 0 0
CALGB-9443 Breast INT-0151 ECOG CL 11/1/1999 1 0 0 0
CALGB-9450 Lymphomas
ECOG CL 4/15/1997 1 0 0 0
CALGB-9462 Other
CALGB CL 12/2/1996 1 0 0 0
CALGB-9466 Lung Non-Small Cell
ECOG CL 1/5/1998 1 0 0 0
CALGB-9473 Intervention Study

Closed 5/31/2002 0 0.5


CALGB-9480 Genitourinary INT-0159 CALGB CL 7/15/1998 1 0.5 0 0 0.5 CC CREDIT FOR QOL
CALGB-9481 Gastrointestinal C9481 CALGB CL 12/29/2000 1 0.5 0 0
CALGB-9483 Gastrointestinal INT-0147 RTOG CL 2/14/1997 1 0 0 0
CALGB-9484 Breast

CL 9/1/1999 0 0 0 0
CALGB-9490 Other E4Z93 ECOG CL 11/29/1999 0 0.7 0 0 CREDIT INCREASED FROM 0.5 TO 0.7 AS OF 06/01/98
CALGB-9491 Gastrointestinal INT-0144 SWOG CL 8/1/2000 1 0 0 0
CALGB-9492 Genitourinary

CL 3/1/1997 0 0 0 0
CALGB-9493 Genitourinary INT-0086 SWOG CL 1/1/1997 1 0 0 0
CALGB-9494 Breast INT-0142 ECOG CL 1/24/1997 1 0 0 0
CALGB-9495 Lung Non-Small Cell INT-0160 SWOG CL 8/1/1999 1 0 0 0
CALGB-9496 Breast INT-0121 ECOG CL 8/3/1998 1.5 0 0 0 HIGH PRIORITY
CALGB-9497 Lymphomas, Hodgkin's Disease
SWOG CL 4/20/2000 0 0.5 0 0 QOL STUDY
CALGB-9498 Gastrointestinal INT-0153 SWOG CL 12/15/1999 1 0 0 0
CALGB-9499 Head and Neck
MDA CL 6/30/1999 0 1 0 0 1.O CREDIT FOR YEAR ONE; 0.3 CREDIT FOR EACH ADDITIONAL YEAR.
CALGB-9511 Leukemia, Acute
CALGB CL 12/15/1997 1 0 0 0
CALGB-9530 Lung
CALGB CL 3/15/1997 1 0 0 0
CALGB-9531 Lung Non-Small Cell
CALGB CL 7/15/1999 1 0 0 0
CALGB-9532 Lung Non-Small Cell
CALGB CL 7/15/1996 1 0 0 0
CALGB-9534 Lung Non-Small Cell
CALGB CL 2/26/1999 1 0 0 0
CALGB-9550 Lymphomas
CALGB CL 8/31/1999 1 0 0 0
CALGB-9551 Lymphomas, Hodgkin's Disease
CALGB CL 10/15/2000 1 0 0 0
CALGB-9565 Solid
CALGB CL 7/15/1998 1 0 0 0
CALGB-9570 Other
CALGB CL 1/15/1999 0 0 0 0
CALGB-9583 Genitourinary
CALGB CL 5/31/2000 1 0 0 0
CALGB-9590 Other INT-0156 ECOG CL 2/27/1997 1 0 0 0
CALGB-9592 Lung Non-Small Cell INT-0139 RTOG CL 11/30/2001 1.5 0 0 0 HIGH PRIORITY
CALGB-9593 Genitourinary
NCIC CL 3/31/1997 1 0 0 0
CALGB-9594 Genitourinary INT-0162 SWOG AC
1 0.5 0 0
CALGB-9620 Leukemia, Acute
CALGB CL 11/15/2000 1 0 0 0
CALGB-9621 Leukemia, Acute
CALGB CL 3/31/2000 1.1 0 0 0 0.1 RX CREDIT FOR MDR MODULATION/CYTOGENETIC RISK
CALGB-9631 CNS, Pituitary
CALGB CL 7/15/1997 1 0 0 0
CALGB-9633 Lung Non-Small Cell CALGB-9633 CALGB CL 1/6/2004 1 0 0 0
CALGB-9640 Breast S9623 SWOG CL 2/15/2001 1.1 0 0 0 0.1 Rx Credit is for Biomarker component of protocol
CALGB-9650 Lymphomas Non-Hodgkin's
CALGB CL 10/15/2000 1 0 0 0
CALGB-9661 Solid
CALGB CL 3/31/2000 1 0 0 0
CALGB-9662 Lymphomas Non-Hodgkin's
CALGB CL 1/31/2001 0.1 0 0 0
CALGB-9663 Genitourinary
CALGB CL 3/30/2001 0.1 0 0 0 COMPANION STUDY TO CALGB-9480 AND CALGB-9680
CALGB-9665 Leukemia, Acute
CALGB AC
0.1 0 0 0
CALGB-9667 Gastrointestinal
ECOG CL 2/15/2001 0 0 0 0
CALGB-9670 Breast
CALGB CL 6/30/1999 0 0 0 0 DESCRIPTIVE STUDY: NO RX OR CC CREDITS GIVEN
CALGB-9680 Genitourinary
CALGB CL 3/9/1998 1 0 0 0
CALGB-9682 Genitourinary
CALGB CL 5/4/2001 1 0 0 0
CALGB-9683 Gastrointestinal
CALGB CL 4/30/1998 1 0 0 0
CALGB-9687 Genitourinary CALGB-9687 CALGB CL 3/15/2006 1 0 0 0
CALGB-9710 Leukemia, Acute CALGB-9170 CALGB CL 3/29/2005 1
0 0
CALGB-9712 Leukemia, Chronic
CALGB CL 1/31/2000 1 0 0 0
CALGB-9720 Leukemia, Acute
CALGB CL 4/30/2002 1 0 0 0
CALGB-9730 Lung Non-Small Cell
CALGB CL 12/29/2000 1 0.5 0 0 0.5 CC CREDIT FOR QOL
CALGB-9731 Lung Non-Small Cell
CALGB CL 4/15/1998 1 0 0 0
CALGB-9733 Other
CALGB CL 1/29/1999 1 0 0 0
CALGB-9740 Breast S9631 SWOG CL 3/1/2000 0.1 0 0 0
CALGB-9741 Breast C9741 CALGB CL 3/31/1999 1 0 0 0 INTERGROUP W/CALGB;NCCTG;SWOG;ECOG
CALGB-9760 Leukemia, Acute
CALGB AC
0.1 0 0 0 COMPANION TO CALGB-9621 & 9720
CALGB-9761 Lung Non-Small Cell
CALGB CL 1/31/2002 0.1 0 0 0
CALGB-9762 Other
CALGB CL 11/27/2002 1 0 0 0
CALGB-9763 Solid
CALGB CL 1/31/2002 1 0 0 0
CALGB-9764 Lymphomas Non-Hodgkin's
CALGB CL 5/23/2005 0.1
0 0
CALGB-9767 Leukemia, Acute
CALGB CL 11/15/2000 0.1 0 0 0 CORRELATIVE STUDY
CALGB-9768 Leukemia, Acute
CALGB CL 4/22/2002 0.1 0 0 0
CALGB-9769 Leukemia, Acute
CALGB CL 2/20/2002 0.1 0 0 0
CALGB-9770 Gastrointestinal E1295 ECOG CL 5/19/2000 0 0.5 0 0
CALGB-9780 Genitourinary
CALGB CL 12/21/1998 1 0 0 0 NO CREDIT FOR QOL
CALGB-9782 Genitourinary
CALGB CL 7/27/2001 1 0 0 0 NO CREDIT FOR QOL
CALGB-9790 Other S9628 SWOG CL 3/15/2003 1 0 0 0
CALGB-9791 Gynecologic GOG-164 GOG CL 5/10/1999 1 0.5 0 0 0.5 CC CRD IS FOR PTS ENROLLED ON QOL
CALGB-9792 Breast S9702 SWOG CL 7/15/1999 0.1 0 0 0 MARKER STUDY FOR S9623
CALGB-9793 Lymphomas Non-Hodgkin's E4494 ECOG CL 7/12/2001 1 0 0 0
CALGB-9794 Breast S9445 SWOG CL 10/1/1998 0 0 0 0
CALGB-9795 Lung Non-Small Cell JBR10 NCIC CL 4/30/2001 1 0 0 0
CALGB-9840 Breast CALGB-9840 CALGB CL 11/14/2003 1 0 0 0
CALGB-9862 Leukemia, Acute
CALGB AC
0.1
0 0
CALGB-9863 Hepatic
CALGB CL 7/31/2001 1 0 0 0
CALGB-9865 Gastrointestinal
CALGB CL 8/30/2002 0.1 0 0 0
CALGB-9870 Head and Neck
CALGB CL 3/30/2000 0 0.5 0 0 COMPANION TO C9781 - CALGB ONLY
CALGB-9871 Other
CALGB CL 8/1/2003 1 0 0 0
CALGB-9872 Descriptive

Closed 4/1/2005 0 0.1

0.1 per case + 0.1 for 1st control + 0.1 for 2nd control = 0.3
CALGB-99808 Genitourinary RTOG-0524 RTOG CL 1/15/2003 1
0 0 Previously assigned 0.8 CC credit deleted based on instructions from SWOG that this component of the study is funded via a pharmaceutical contract.
CALGB-99809 Genitourinary
CALGB CL 10/31/2005 1
0 0
CALGB-99811 Genitourinary
CALGB CL 6/30/2006 1
0 0
CALGB-99813 Genitourinary
CALGB CL 7/23/2001 1
0 0
CALGB-99901 Genitourinary
CALGB CL 9/17/2001 1
0 0
CALGB-99903 Genitourinary
CALGB CL 3/15/2002 1
0 0
CALGB-99904 Genitourinary S9921 SWOG CL 1/12/2007 1
0 0
CALGB-99908 Genitourinary E4897 ECOG CL 6/13/2001 1 0.5 0 0 0.5 CC Credit for QOL
E1A95(C) Multiple Myeloma E1A95 ECOG CL 5/10/2000 1 0 0 0
E8892(C) Genitourinary E8892 ECOG CL 5/27/1998 1 0.5 0 0 INTERGROUP W/ECOG;SWOG & CALGB CC CREDIT FOR QOL
NCIC-PR.11 Genitourinary NCIC-PR.11 CALGB AC
1 0.5 0 0 0.5 Cancer Control for QOL component of trial
RTOG-0623 Lung RTOG-0623 RTOG AC
1 0 0 0
S0002 Intervention Study S0002
Closed 1/1/2004
0.7


S0344 Other S0344 SWOG CL 1/15/2007 1 0.5 0 0 Cancer Control credit for QOL
S0346 Sarcoma S0346 SWOG CL 12/1/2006 1 0 0 0